PNPLA3 and metabolic dysfunction-associated steatotic liver disease: also proved that MASLD patients carrying the PNPLA3 gene variant exhibited more severe metabolic abnormalities, such as elevated liver enzymes, higher LDL cholesterol, and increased IR, compared to non-MASLD patients [58].